In addition to neuroendocrine transdifferentiation, other molecular features such as apoptosis resistance, loss of retinoblastoma protein (pRB), and gene amplification of Aurora, polo-like kinases (PLK1), and c-Myc, also coordinate the aggressive PCa phenotype [7, 27]. The gene discussed is RB1; the disease is posterior cortical atrophy.